Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Aduhelm (Biogen, Eisai) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
BIIB Biogen is mentioned as a key player in the Aduhelm market, developing treatments for Alzheimer's. The article discusses their product Leqembi Iqik and its self-injectable formulation, indicating ongoing innovation and market presence. However, the sentiment is neutral as it focuses on market dynamics rather than specific company performance. ABBV AbbVie is mentioned for its acquisition of Aliada Therapeutics to bolster its Alzheimer's pipeline. This strategic move suggests a positive outlook on the Alzheimer's market, but the article provides limited detail on the direct impact or future prospects for AbbVie, resulting in a neutral sentiment.

Aduhelm (Biogen, Eisai) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Aduhelm Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.

The Aduhelm market has witnessed significant growth driven by multiple factors, including an aging global population, advances in amyloid research, and an increase in neurological clinical trials. The forecast period projects further expansion due to a growing Alzheimer's patient pool and rising demand for early intervention therapies. Key trends in this period encompass a focus on disease-modifying therapies, heightened use of monoclonal antibodies, and a push for early Alzheimer's diagnosis.

Alzheimer's disease, a progressive neurodegenerative disorder, is becoming increasingly prevalent, fostering the growth of the Aduhelm market. In May 2024, the Alzheimer Society estimated that 982,000 individuals in the UK were living with dementia, with projections rising to 1.4 million by 2040. Aduhelm, developed by Biogen and Eisai Co., Ltd., treats Alzheimer's by targeting amyloid-beta plaques in the brain.

Innovative solutions are shaping the Aduhelm market as companies focus on patient convenience and adherence to treatment. Self-injectable formulations, such as Eisai and Biogen's 2025 introduction of Leqembi Iqik, allow for at-home administration, reducing the need for hospital visits. This self-injectable lecanemab pen offers a user-friendly design and aims to alleviate needle anxiety while maintaining the safety and efficacy of intravenous options.

Strategic acquisitions are further bolstering market developments. In December 2024, AbbVie acquired Aliada Therapeutics for $1.4 billion, integrating Aliada's blood-brain barrier delivery technology into its Alzheimer's pipeline. Major market players include Biogen Inc. and Eisai Co. Ltd.

Geographically, North America dominated the Aduhelm market in 2025, with Asia-Pacific expected to be the fastest-growing region. Regions covered include Asia-Pacific, Western and Eastern Europe, North and South America, and the Middle East and Africa. Tariffs have impacted the market by increasing costs for imported biologic components, notably in Europe and Asia-Pacific. Meanwhile, local manufacturing is expanding to ensure long-term supply stability.

The comprehensive Aduhelm market research report offers vital statistics, including global industry size, regional shares, and competitive landscape analysis. It delivers an all-encompassing perspective on current trends and future opportunities within the industry.

The market for Aduhelm includes sales of Aduhelm injection, aducanumab-avwa, donanemab, and Aricept. The market values are based on the revenues from manufacturers and related services to various end users-including adults with mild cognitive impairment and mild dementia-distributed through hospitals, clinics, and pharmacies.

Report Highlights

Key Technologies & Future Trends

Report Scope

For more information about this report visit https://www.researchandmarkets.com/r/jff08r

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.